chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site vesicles, Injection site warmth, Urticaria
Clinical narrative: On 11-19-13 pt first had onset of red hot to touch at area of injection was seen by physician after line marked on pt with redness spreading. On 11-20-13 mom brought pt in due to blisters that had developed around injection site, redness and hot to touch spreading and hives and welts occurring on various places of patient's body. Pt was given prescription for steroid but also went to ER for treatment that night.
Age: 48.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Local swelling
Clinical narrative: Pt. called Mon. 11/25/13 to report redness and swelling (R) arm 2x the size of arm starting at 3 PM and increasing next day. Ice, elevation - Monday 11/25 - symptoms disappeared. Pt. refused transport to ER on 11/23/13.
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Pain in right arm from day shot was given through till three separate doctor's visits, including 2 rounds of antibiotics and 6 day steroids. Flu shot required by employer. Slight fever 11/19/13.
Age: 63.0
Sex: F
Vaccine: FLU3
Symptoms: Chest pain, Hypoaesthesia, Musculoskeletal pain, Pain
Clinical narrative: Numbness in (L) arm, pain in (L) scapula that radiated to (L) chest under her (L) clavicle. Increased pain trying to lift her (L) arm. Numbness in (L) palm.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site reaction, Urticaria
Clinical narrative: Red welt itchy at site of injection R-arm, Pt called in complaining of itching. Was not able to tell if it was from the bandage or the vaccine itself.
Age: 36.0
Sex: F
Vaccine: SMALL
Symptoms: Injection site erythema, Injection site pruritus, Injection site streaking, Injection site warmth, Lymph node pain
Clinical narrative: 36 y/o F who received primary SPV (LUE) ad Clinic on 13Aug13 (LUE). Calls at 8PM with concern re SPV site- very red, warm, itchy, with streak going toward left axilla and left axillary node enlargement and tenderness. General malaise, but no CP or SOB. Deploying. She is a teacher and is still working.
Age: 36.0
Sex: F
Vaccine: SMALL
Symptoms: Lymphadenopathy, Malaise
Clinical narrative: 36 y/o F who received primary SPV (LUE) ad Clinic on 13Aug13 (LUE). Calls at 8PM with concern re SPV site- very red, warm, itchy, with streak going toward left axilla and left axillary node enlargement and tenderness. General malaise, but no CP or SOB. Deploying. She is a teacher and is still working.
Age: 43.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site rash, Rash
Clinical narrative: Patient called Thursday 11/21 that rash at injection site only, and then called 11/25 that rash is now on forearm of same arm where injection.
Age: 84.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: Patient called on 11/23/13 stating her arm still hurt where she got her flu shot.
Age: 48.0
Sex: F
Vaccine: FLUR3
Symptoms: Cough, Dysphonia, Flushing, Oedema, Urticaria
Clinical narrative: Employee vaccinated with FLUBLOK. Ten minutes post-vaccination she developed hives, facial/upper body flushing and slight edema as well as increasingly persistent cough, raspy voice and vomiting.
Age: 45.0
Sex: M
Vaccine: FLU3
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Very sore arm, not useable.
Age: 11.0
Sex: F
Vaccine: FLU3
Symptoms: Fall, Nausea, Syncope
Clinical narrative: 10-15 minutes after administering flu vaccine 11 year old female became faint and dropped to floor. Responded immediately after and seemed fine with some nausea. Had pt transported for safety precautions. Mother was with child.
Age: 49.0
Sex: M
Vaccine: FLU3
Symptoms: Ageusia, Laboratory test, Weight decreased
Clinical narrative: Patient lost taste. Patient lost weight. Per physician visit, due possibly to flu shot.
Age: 1.35
Sex: M
Vaccine: HIBV, MMR, VARCEL
Symptoms: Febrile convulsion
Clinical narrative: Febrile sz 9 days after MMR, VARIVAX and hib.
Age: 5.0
Sex: M
Vaccine: FLUN4
Symptoms: Vomiting
Clinical narrative: 1130A received FLUMIST intranasally - went to daycare ate lunch vomited large amount 1x at 430 pm.
Age: 59.0
Sex: F
Vaccine: FLU3
Symptoms: Hypersensitivity, Injection site discolouration
Clinical narrative: 3 inches diameter area at the injected site has discoloration. Pt has sensitivity reaction.
Age: 1.0
Sex: M
Vaccine: FLU3, MMR, PNC13, VARCEL
Symptoms: Rash macular, Rash papular
Clinical narrative: Cephalocaudal erythematous macular/papular rash w/cluster on face/trunk and upper extremities.
Age: 8.0
Sex: M
Vaccine: FLUN4
Symptoms: Headache, Oropharyngeal pain, Stridor, Wheezing
Clinical narrative: Child complained of headache and sore throat, within 10-15 minutes after receiving LAIV. Initially, had slight wheezing which increased and had stridor. EPIPEN given at 9:35 a.m. and 911 called. Within few minutes, stridor subsided and breathing improved.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Erythema, Local swelling
Clinical narrative: (L) arm swollen, redness.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Pt reports small rash next AM after ZOSTAVAX shot 11/18/13. Rash had small ring around it. 11/21 - white ring turned into rash had got worse. Pt made MD appt 11/21/13. Followed up w/ pt 11/25. MD told her to take hydrocortisone and BENADRYL. Pt seems better.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site cellulitis, Injection site erythema, Injection site rash, Injection site warmth
Clinical narrative: Pt. received vaccine on 11/22/13. Noticed a warm red rash at site. She went to an urgent care facility and MD gave her an antibiotic for cellulitis on 11/25/13.
Age: 47.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Dermatitis atopic, Injection site pruritus, Injection site rash, Injection site urticaria, Pruritus
Clinical narrative: Information was received from a L.P.N. regarding 47 year old female patient with COPD. On 09-OCT-2013, the patient was vaccinated with PNEUMOVAX23 (Lot # J004387, expiration 04-JAN-2015), 0.5 ml, intramuscular in the left arm. Concomitant therapies included amitriptyline hydrochloride, buspirone hydrochloride, IMITREX, potassium (unspecified), CLARITIN, naproxen and ZOLOFT. On 09-Oct-2013, the patient was also vaccinated with FLUZONE via right arm. The nurse reported that the patient experienced rash, hives and itching of both her arms and shoulders after receiving the PNEUMOVAX23 on 09-OCT-2011. On 11-OCT-2013, the patient was evaluated back in the office and was diagnosed with atopic dermatitis. Treatment included an unspecified skin moisturizer. At the time of this report the outcome of rash, atopic dermatitis, itching, and hives both arms was reported as recovered. Additional information has been requested.
Age: 47.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Rash, Urticaria
Clinical narrative: Information was received from a L.P.N. regarding 47 year old female patient with COPD. On 09-OCT-2013, the patient was vaccinated with PNEUMOVAX23 (Lot # J004387, expiration 04-JAN-2015), 0.5 ml, intramuscular in the left arm. Concomitant therapies included amitriptyline hydrochloride, buspirone hydrochloride, IMITREX, potassium (unspecified), CLARITIN, naproxen and ZOLOFT. On 09-Oct-2013, the patient was also vaccinated with FLUZONE via right arm. The nurse reported that the patient experienced rash, hives and itching of both her arms and shoulders after receiving the PNEUMOVAX23 on 09-OCT-2011. On 11-OCT-2013, the patient was evaluated back in the office and was diagnosed with atopic dermatitis. Treatment included an unspecified skin moisturizer. At the time of this report the outcome of rash, atopic dermatitis, itching, and hives both arms was reported as recovered. Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Injection site swelling, Nodule, Pyrexia
Clinical narrative: Information was received from a pharmacist regarding a 65 year old female patient with "cholesterol", high blood pressure, mood disorder and "thyroid," and a history of some "liver issues" when taking an unspecified form of erythromycin in the past, clarified as hepatitis. On 21-OCT-2013, the patient was vaccinated with PNEUMOVAX23 (dosage not provided) lot# J004332, expiration 26-SEP-2014, intramuscularly. Concomitant therapy included unspecified medications for her cholesterol, high blood pressure, mood disorder and thyroid along with unspecified diet aids. The patient reported to the pharmacist that on an unspecified date after receiving the vaccination, she experienced swelling at the injections site and a fever of 101 degrees Fahrenheit. The patient stated that she had visited her physician on an unspecified date who prescribed her to take Benadryl. The patient told the pharmacist that it took a couple of days before the fever broke. The pharmacist reported that the patient presented to the pharmacy on 29-OCT-2013 and had a "hard know" at the injections site. The outcome of the swelling at the injections site, hard knot at the injections and fever was reported as not recovered. Additional information has been requested
Age: 81.0
Sex: M
Vaccine: PPV
Symptoms: Pneumonia
Clinical narrative: Information was received from a pharmacist regarding an 81 year old male patient with hypertension and allergies to NSAID's and iodines. On 17-OCT-2013, the patient was vaccinated with PNEUMOVAX23, 0.5 ml, intramuscularly in the left arm. Concomitant therapies included DIOVAN. The wife of the patient presented to the pharmacy on 29-OCT-2013 to report that the patient now has pneumonia. The patient was treated with Z-PAK. The outcome of pneumonia was reported as not recovered. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: This spontaneous report as received from a pharmacist via a company representative refers to a patient of unknown age and gender. Medical history and drug reactions/allergies were not reported. On an unknown date, the patient was vaccinated with ZOSTAVAX (lot, dose and route not reported). Concomitant medication was not reported. On an unknown date, the patient experienced redness and swelling on the arm, at the injection site after receiving ZOSTAVAX. The outcome of redness and swelling on the arm, at the injection site after receiving ZOSTAVAX was not reported. Additional information is not expected.
Sex: U
Vaccine: MMR
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse regarding a patient of unknown age and gender with no pertinent medical history reported. On 19-NOV-2013 the patient was vaccinated with a dose of MMR II (lot # 1648AA, expiration date 21-OCT-2013) (0.5 ml, subcutaneous). No other suspect therapies or concomitant medications were reported. The nurse reported that the patient received a dose that has expired on 21-OCT-2013. No adverse effect reported. Additional information has been requested.
Age: 49.0
Sex: F
Vaccine: PPV
Symptoms: Adverse reaction
Clinical narrative: This spontaneous report was received from Novartis an was assigned manufacturer report number PUS2013US116373 refers to a currently 50 years old female patient. On 11-FEB-2013, the patient was vaccinated with a dose of PNEUMOVAX23 (route, dose and lot # not reported). On an unknown date, the patient had a reaction after vaccination with PNEUMOVAX23. The outcome of reaction was unknown. This was originally reported by a nurse. Additional information has been requested.
Age: 69.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: This spontaneous report was received from a doctor of pharmacy concerning a 69 year old male patient with no pertinent medical history and no drug reactions or allergies. On 19-NOV-2013, the patient was vaccinated with 0.65 milliliter (ml) of ZOSTAVAX (lot number and expiry date were reported as J006830 and 14-SEP-2013 respectively), subcutaneously in the left arm. Other suspect therapy included a dose of Influenza Virus Vaccine (manufacturer unknown) (lot number, expiry date, dose and route unspecified) administered approximately on 24-OCT-2013 (reported as about 4 weeks ago). No concomitant therapy was reported. On an unknown date in November 2013, the patient developed rash, swelling, warmth and redness on his left arm at the injection site after receiving ZOSTAVAX. The affected area was about 2 inches in diameter. The patient sought medical attention (patient came back into the pharmacy). No treatment was provided. The outcome all the events was reported as not resolved. The relatedness for all the events was unknown for ZOSTAVAX and Influenza Virus Vaccine (manufacturer unknown). Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Adverse reaction
Clinical narrative: Information was received from a pharmacist, who reported that a physician reported to him that an anonymous patient (demographics unknown) was vaccinated with PNEUMOVAX23 (date of vaccination, dosage and route of administration not provided). On an unknown date, the patient developed an unspecified adverse reaction after receiving PNEUMOVAX23. The outcome of unspecified adverse reaction is unknown. Additional information is not expected.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Expired drug administered, No adverse event
Clinical narrative: Information was received from a pharmacist concerning a patient of unknown age. On 30-OCT-2013, the patient was vaccinated with PNEUMOVAX23, (Lot# 0811AA, expiration 15-MAR-2013), 0.5 ml, intramuscular. The pharmacist reported that the patient received an expired dose of PNEUMOVAX23. No adverse effect reported. No further information was provided. Additional information has been requested.
Age: 16.0
Sex: M
Vaccine: FLU3, MNQ, FLU3, MNQ
Symptoms: Convulsion, Dyskinesia, Hand deformity, Musculoskeletal stiffness, Syncope
Clinical narrative: Case number PHHY2013US032687 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 484372) website on 04 Apr 2013, with a follow up received from the Quality Assurance (QA ref: 222353) department on 21 Nov 2013: This report refers to a 16-year-old male patient. Current condition of this patient include autism and mild mental retardation. He was vaccinated with MENVEO (batch number: A12024, expiry date: Dec 2014) to left arm and seasonal influenza vaccine (other manufacturer: batch number: U4544EA) to left arm on 30 Jan 2013. On 03 Feb 2013, the patient experienced stiff arm for one minute while he was flopping his arm and then his hand became claw. Patient visited emergency room. Patient also experienced fainting seizure. Outcome of the events were reported as complete recovery. Seriousness and causality were not reported. Based on the batch review, it was stated that the concerned MENVEO (batch number: A12024) was manufactured in accordance with approved internal procedures and it was in compliance with the current good manufacturing practices (cGMP) requirements. Follow up received from the QA department on 21 Nov 2013: Updated Batch review report.
Age: 16.0
Sex: M
Vaccine: FLU3, MNQ, FLU3, MNQ
Symptoms: Convulsion, Hand deformity, Hypotonia, Musculoskeletal stiffness, Syncope
Clinical narrative: Case number PHHY2013US032687 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 484372) website on 04 Apr 2013, with a follow up received from the Quality Assurance (QA ref: 222353) department on 21 Nov 2013: This report refers to a 16-year-old male patient. Current condition of this patient include autism and mild mental retardation. He was vaccinated with MENVEO (batch number: A12024, expiry date: Dec 2014) to left arm and seasonal influenza vaccine (other manufacturer: batch number: U4544EA) to left arm on 30 Jan 2013. On 03 Feb 2013, the patient experienced stiff arm for one minute while he was flopping his arm and then his hand became claw. Patient visited emergency room. Patient also experienced fainting seizure. Outcome of the events were reported as complete recovery. Seriousness and causality were not reported. Based on the batch review, it was stated that the concerned MENVEO (batch number: A12024) was manufactured in accordance with approved internal procedures and it was in compliance with the current good manufacturing practices (cGMP) requirements. Follow up received from the QA department on 21 Nov 2013: Updated Batch review report.
Age: 20.0
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Hyperhidrosis, Loss of consciousness, Pallor, Presyncope, Unresponsive to stimuli
Clinical narrative: Case number PHHY2013US127852, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 499836) website on 11 Nov 2013, with a follow up received from the QA department (Ref: 263778) on 20 Nov 2013. This report refers to a 20-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A12013, Expiry date: Feb 2014) in the left arm on 12 Aug 2013. At the same time, he also received PPD (tuberculin protein derivative). On the same date, 5 minutes after vaccination he became pale and passed out in chair. He was unresponsive and became sweaty. He was given a popsicle. His vital signs at 9:27 am showed, blood pressure as 108/60, pulse 53, respiratory rate 16 and body temperature 97.5. At 09:55, his BP was 111/50, pulse 68, respiratory rate 14 and oxygen saturation 99%. He became pink, warm and skin became dry. The patient felt it was a vasovagal reaction. It was reported that he had eaten and drank that morning prior to visit. The patient left in care of mom drinking more water. The patient recovered on same day. The seriousness and causality of the events were not reported. Based on the batch review, it was stated that the concerned MENVEO (batch number: A12013) was manufactured in accordance with approved internal procedures and it was in compliance with the current good manufacturing practices (cGMP) requirements. Follow up received from the QA department on 20 Nov 2013: Updated batch review report.
Age: 20.0
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Hyperhidrosis, Hypotension, Loss of consciousness, Pallor, Presyncope
Clinical narrative: Case number PHHY2013US127852, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 499836) website on 11 Nov 2013, with a follow up received from the QA department (Ref: 263778) on 20 Nov 2013. This report refers to a 20-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A12013, Expiry date: Feb 2014) in the left arm on 12 Aug 2013. At the same time, he also received PPD (tuberculin protein derivative). On the same date, 5 minutes after vaccination he became pale and passed out in chair. He was unresponsive and became sweaty. He was given a popsicle. His vital signs at 9:27 am showed, blood pressure as 108/60, pulse 53, respiratory rate 16 and body temperature 97.5. At 09:55, his BP was 111/50, pulse 68, respiratory rate 14 and oxygen saturation 99%. He became pink, warm and skin became dry. The patient felt it was a vasovagal reaction. It was reported that he had eaten and drank that morning prior to visit. The patient left in care of mom drinking more water. The patient recovered on same day. The seriousness and causality of the events were not reported. Based on the batch review, it was stated that the concerned MENVEO (batch number: A12013) was manufactured in accordance with approved internal procedures and it was in compliance with the current good manufacturing practices (cGMP) requirements. Follow up received from the QA department on 20 Nov 2013: Updated batch review report.
Age: 20.0
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Unresponsive to stimuli
Clinical narrative: Case number PHHY2013US127852, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 499836) website on 11 Nov 2013, with a follow up received from the QA department (Ref: 263778) on 20 Nov 2013. This report refers to a 20-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A12013, Expiry date: Feb 2014) in the left arm on 12 Aug 2013. At the same time, he also received PPD (tuberculin protein derivative). On the same date, 5 minutes after vaccination he became pale and passed out in chair. He was unresponsive and became sweaty. He was given a popsicle. His vital signs at 9:27 am showed, blood pressure as 108/60, pulse 53, respiratory rate 16 and body temperature 97.5. At 09:55, his BP was 111/50, pulse 68, respiratory rate 14 and oxygen saturation 99%. He became pink, warm and skin became dry. The patient felt it was a vasovagal reaction. It was reported that he had eaten and drank that morning prior to visit. The patient left in care of mom drinking more water. The patient recovered on same day. The seriousness and causality of the events were not reported. Based on the batch review, it was stated that the concerned MENVEO (batch number: A12013) was manufactured in accordance with approved internal procedures and it was in compliance with the current good manufacturing practices (cGMP) requirements. Follow up received from the QA department on 20 Nov 2013: Updated batch review report.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Abasia, Abdominal distension, Abdominal pain upper, Abnormal loss of weight, Activities of daily living impaired
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Alopecia, Anxiety, Arthralgia, Autism, Back pain
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Bladder disorder, Blindness, Blindness unilateral, Blister, Blood test
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Bone pain, Chest pain, Chronic fatigue syndrome, Coccydynia, Computerised tomogram
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Constipation, Convulsion, Deafness, Decreased appetite, Depression
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Diarrhoea, Dizziness, Dysarthria, Dyslexia, Dyspnoea
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Electroencephalogram, Erythema, Fatigue, Feeling abnormal, Feeling of body temperature change
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Functional gastrointestinal disorder, Hallucination, Headache, Hemiplegia, Hepatomegaly
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Hyperacusis, Influenza like illness, Injection site pain, Injection site pruritus, Laboratory test
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Local swelling, Lumbar puncture, Migraine, Multiple chemical sensitivity, Muscle spasms
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Muscle tightness, Muscle twitching, Myalgia, Nausea, Neoplasm
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Neuralgia, Nuclear magnetic resonance imaging, Oedema, Oropharyngeal pain, Pallor
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Panic attack, Paraesthesia, Parosmia, Personality change, Photophobia
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Pneumonia, Pruritus, Pyrexia, Rash, Renal disorder
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Sleep disorder, Swelling, Syncope, Temperature intolerance, Thrombosis
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Tooth disorder, Tremor, Tumour excision, Urinary incontinence, Urinary tract infection
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Uterine spasm, Vomiting
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4, MNQ, HPV4
Symptoms: Activities of daily living impaired, Convulsion
Clinical narrative: This spontaneous report as from a consumer via social media who obtained the information from the campaign against the HPV vaccine and released the video shown at last week's Briefing, who reported that a 21 years old female patient who loved photography, swimming, biking and loved doing fun things on an unknown date, was vaccinated with a dose of GARDASIL (dose, route, lot number and expiration date were not reported). The patient was unable to continue with participating in the video, as she experienced a seizure during the filming on an unspecified date. At the time of the report, the patient's outcome was unknown. The patient stated that it was not a coincidence that she could no longer enjoy her fun activities. Upon internal review seizure was considered to be medically singificant. This is one of several reports received from the same source. No further information is available.
Age: 75.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Arthralgia, Dizziness, Headache, Myalgia, Nausea
Clinical narrative: Head ache - nausea - lightheadedness, heavy joint pain all over, especially knees - back, ankles with muscle pain level of 4 to 5, also leg cramps, sore throat. (From onset 9-16-2013 to present, the symptoms still exist in a milder form) joint and muscle skeletal pain and sore throat still exist in milder forms.
Age: 75.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Arthralgia, Dizziness, Headache, Muscle spasms, Musculoskeletal pain
Clinical narrative: Head ache - nausea - lightheadedness, heavy joint pain all over, especially knees - back, ankles with muscle pain level of 4 to 5, also leg cramps, sore throat. (From onset 9-16-2013 to present, the symptoms still exist in a milder form) joint and muscle skeletal pain and sore throat still exist in milder forms.
Age: 75.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Myalgia, Nausea, Oropharyngeal pain
Clinical narrative: Head ache - nausea - lightheadedness, heavy joint pain all over, especially knees - back, ankles with muscle pain level of 4 to 5, also leg cramps, sore throat. (From onset 9-16-2013 to present, the symptoms still exist in a milder form) joint and muscle skeletal pain and sore throat still exist in milder forms.
Age: 78.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Arthralgia, Dizziness, Headache, Myalgia, Nausea
Clinical narrative: Headache - nausea - lightheadedness. Severe joint pain, ankles - knees - wrists - neck. Pain all over - leg cramps (from on Sat 8-27-13 to present) symptoms still exist in a milder form. Leg cramps joint and musculoskeletal pain and sore throat still exist in mild form. Permission granted to contact Dr. for this data.
Age: 78.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Arthralgia, Dizziness, Headache, Muscle spasms, Musculoskeletal pain
Clinical narrative: Headache - nausea - lightheadedness. Severe joint pain, ankles - knees - wrists - neck. Pain all over - leg cramps (from on Sat 8-27-13 to present) symptoms still exist in a milder form. Leg cramps joint and musculoskeletal pain and sore throat still exist in mild form. Permission granted to contact Dr. for this data.
Age: 78.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Nausea, Neck pain, Oropharyngeal pain, Pain
Clinical narrative: Headache - nausea - lightheadedness. Severe joint pain, ankles - knees - wrists - neck. Pain all over - leg cramps (from on Sat 8-27-13 to present) symptoms still exist in a milder form. Leg cramps joint and musculoskeletal pain and sore throat still exist in mild form. Permission granted to contact Dr. for this data.
Sex: M
Vaccine: VARZOS
Symptoms: Plasma cell myeloma
Clinical narrative: This spontaneous report as received from a pharmacist refers to a male patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX, (dose, lot number, expiry date and route was not reported). No concomitant medication was reported. On an unknown date the patient experienced multiple myeloma. It was reported that the patient is to begin treatment for multiple myeloma with BORTEZOMIB. The outcome of multiple myeloma was unknown. The reporter considered the event multiple myeloma to be life threatening. Upon internal review the event multiple myeloma was considered to be medically significant. Additional information has been requested.
Age: 17.0
Sex: M
Vaccine: FLU3, HPV4, FLU3, HPV4
Symptoms: Blindness, Eye inflammation, Eye pain, Intracranial pressure increased, Lumbar puncture
Clinical narrative: This spontaneous report as received from a consumer refers to a 17 year old male patient (consumer's son). On 01-NOV-2013 the patient was vaccinated with GARDASIL (dose, route of administration and lot #batch# were not reported). No medical history and concomitant medication were reported. On 11-NOV-2013, the patient experienced pain, vision loss and nausea after receiving the GARDASIL. It was reported that the patient could open his eyelids but experienced pain when he tried to move his eyes. On an unknown date of November 2013, he was seen by an ophthalmologist, who diagnosed as optic neuritis and inflammation of the optic nerve for both eyes. He was referred to a neurologist. On an unknown date of November 2013, a vision field test was done and some loss of vision was noted. On 13-NOV-2013, the patient was taken to see a neurologist and an MRI was done and it showed inflammation. The patient then underwent a lumbar puncture to decrease the intracranial pressure (dates unspecified, November 2013). The patient sought medical attention (office visit). The patient was also given intravenous steroid therapy at the hospital (name of hospital not provided). It was reported that the patient was not admitted to the hospital but goes almost daily for treatments. The consumer also reported that as a consequence of the lumbar puncture, the patient experienced increased pain and nausea. The patient eye pain has increased since it was first noticed. The outcome of the reported events was reported as not recovered. It was also reported that both physicians have stated optic neuritis and inflammation of the optic nerve for both eyes have developed from receiving the GARDASIL. Upon internal review the event 'vision loss' was considered to be medically significant. Additional information has been requested.
Age: 17.0
Sex: M
Vaccine: FLU3, HPV4, FLU3, HPV4
Symptoms: Nausea, Nuclear magnetic resonance imaging abnormal, Optic neuritis, Pain, Visual field tests abnormal
Clinical narrative: This spontaneous report as received from a consumer refers to a 17 year old male patient (consumer's son). On 01-NOV-2013 the patient was vaccinated with GARDASIL (dose, route of administration and lot #batch# were not reported). No medical history and concomitant medication were reported. On 11-NOV-2013, the patient experienced pain, vision loss and nausea after receiving the GARDASIL. It was reported that the patient could open his eyelids but experienced pain when he tried to move his eyes. On an unknown date of November 2013, he was seen by an ophthalmologist, who diagnosed as optic neuritis and inflammation of the optic nerve for both eyes. He was referred to a neurologist. On an unknown date of November 2013, a vision field test was done and some loss of vision was noted. On 13-NOV-2013, the patient was taken to see a neurologist and an MRI was done and it showed inflammation. The patient then underwent a lumbar puncture to decrease the intracranial pressure (dates unspecified, November 2013). The patient sought medical attention (office visit). The patient was also given intravenous steroid therapy at the hospital (name of hospital not provided). It was reported that the patient was not admitted to the hospital but goes almost daily for treatments. The consumer also reported that as a consequence of the lumbar puncture, the patient experienced increased pain and nausea. The patient eye pain has increased since it was first noticed. The outcome of the reported events was reported as not recovered. It was also reported that both physicians have stated optic neuritis and inflammation of the optic nerve for both eyes have developed from receiving the GARDASIL. Upon internal review the event 'vision loss' was considered to be medically significant. Additional information has been requested.